Streptomyces sp producing tautomycetin and immunosuppressant comprising tautomycetin as active ingredient
1. Field of the Invention The present invention relates to Streptomyces sp. producing tautomycetin which possesses an immunosuppressive or antibacterial activities, a process for preparing tautomycetin from the said microorganism, and an immunosuppressant or immunosuppressive pharmaceutical composit...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
19.08.2003
|
Online Access | Get full text |
Cover
Loading…
Abstract | 1. Field of the Invention
The present invention relates to Streptomyces sp. producing tautomycetin which possesses an immunosuppressive or antibacterial activities, a process for preparing tautomycetin from the said microorganism, and an immunosuppressant or immunosuppressive pharmaceutical composition comprising tautomycetin as an active ingredient which suppresses interleukin-2 production, CD69 and interleukin-2 receptor(IL-2R) expression on the cell surface, and graft rejection in the organ transplantation. The present inventors isolated a soil microorganism which produces a substance possessing antibiotic and immunosuppressive activities, and identified the said microorganism and substance as a novel Streptomyces sp. and tautomycetin, respectively. Further, the present inventors developed a method of manufacturing the tautomycetin in a large scale from the culture of the said microorganism and discovered that tautomycetin suppresses mouse mixed lymphocyte reaction(MLR) and the expression of IL-2 based on a series of experiments employing cell line transfected with a recombinant gene. |
---|---|
AbstractList | 1. Field of the Invention
The present invention relates to Streptomyces sp. producing tautomycetin which possesses an immunosuppressive or antibacterial activities, a process for preparing tautomycetin from the said microorganism, and an immunosuppressant or immunosuppressive pharmaceutical composition comprising tautomycetin as an active ingredient which suppresses interleukin-2 production, CD69 and interleukin-2 receptor(IL-2R) expression on the cell surface, and graft rejection in the organ transplantation. The present inventors isolated a soil microorganism which produces a substance possessing antibiotic and immunosuppressive activities, and identified the said microorganism and substance as a novel Streptomyces sp. and tautomycetin, respectively. Further, the present inventors developed a method of manufacturing the tautomycetin in a large scale from the culture of the said microorganism and discovered that tautomycetin suppresses mouse mixed lymphocyte reaction(MLR) and the expression of IL-2 based on a series of experiments employing cell line transfected with a recombinant gene. |
Author | Lyu, Nam Hyun Chun, Hyoung Sik Kim, Jung Woo Kim, Jong Gwan Son, Hyeog Jin Chang, Hung Bae Moon, Seung Kee Hong, Chung Il |
Author_xml | – sequence: 1 fullname: Chun, Hyoung Sik – sequence: 2 fullname: Kim, Jong Gwan – sequence: 3 fullname: Chang, Hung Bae – sequence: 4 fullname: Moon, Seung Kee – sequence: 5 fullname: Son, Hyeog Jin – sequence: 6 fullname: Hong, Chung Il – sequence: 7 fullname: Kim, Jung Woo – sequence: 8 fullname: Lyu, Nam Hyun |
BookMark | eNqNyrsKAkEMheEptPD2DnkBYUFdthfFXnsJs3EJOJkwyQi-vSva2Vj9cM43DxPJQrPAZy-kntMzkoEpaMl9jSwDONbP7iyA0gOnVCVbVS1khuIQc9LC9qsNMDo_CMarUM8kvgzTG96NVt8uAhwPl_1pXU3RR2DXoeA7Tds2XbPdbf4gL4bURYY |
ContentType | Patent |
CorporateAuthor | Chong Kun Dang Corporation |
CorporateAuthor_xml | – name: Chong Kun Dang Corporation |
DBID | EFH |
DatabaseName | USPTO Issued Patents |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EFH name: USPTO Issued Patents url: http://www.uspto.gov/patft/index.html sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
ExternalDocumentID | 06608045 |
GroupedDBID | EFH |
ID | FETCH-uspatents_grants_066080453 |
IEDL.DBID | EFH |
IngestDate | Sun Mar 05 22:31:20 EST 2023 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-uspatents_grants_066080453 |
OpenAccessLink | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6608045 |
ParticipantIDs | uspatents_grants_06608045 |
PatentNumber | 6608045 |
PublicationCentury | 2000 |
PublicationDate | 20030819 |
PublicationDateYYYYMMDD | 2003-08-19 |
PublicationDate_xml | – month: 08 year: 2003 text: 20030819 day: 19 |
PublicationDecade | 2000 |
PublicationYear | 2003 |
References | (08188533) 19960700 Cheng et al., J. Antibiot. (1989), 42(1), 141-4. Katari, S.R. et al., Clinical Features of Acute Reversible Tacrolimus (FK506) Nephrotoxicity in Kidney Transplant Recipients; Clinical Transplantation; vol. 11; pp. 237-242 (1997). Sun Lee, et al.; "A Simplified Model for Heterotopic Rat Heart Transplantation"; vol. 33; pp. 438-442 (1982). Giroux (4439443) 19840300 James E.F. Reynolds, et al.; Martindale The Extra Pharmacopoeia; 31st edition; London Royal Pharmaceutical Society, pp. 557-562 (1996). Wei Li, et al.; Regulation of the Nuclear Factor of Activated T Cells in Stably Transfected Jurkat Cell Clones; Biochemical and Biophysical Research Communications; vol. 219; pp. 96-99 (1996). Härri et al. (4117118) 19780900 Ackerman (5204329) 19930400 Sakuda et al., Biosci., Biotechnol., Biochem. (1995), 59(1), 133-4. Calne (5100899) 19920300 |
References_xml | – year: 19780900 ident: 4117118 contributor: fullname: Härri et al. – year: 19960700 ident: 08188533 – year: 19920300 ident: 5100899 contributor: fullname: Calne – year: 19930400 ident: 5204329 contributor: fullname: Ackerman – year: 19840300 ident: 4439443 contributor: fullname: Giroux |
Score | 2.5758517 |
Snippet | 1. Field of the Invention
The present invention relates to Streptomyces sp. producing tautomycetin which possesses an immunosuppressive or antibacterial... |
SourceID | uspatents |
SourceType | Open Access Repository |
Title | Streptomyces sp producing tautomycetin and immunosuppressant comprising tautomycetin as active ingredient |
URI | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6608045 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED62IahPiorTKXnwNdp2WX88y0oRlD0o7G1cmygFl5YmRfzvvaQyBNHXXEiOJJe7I999AbiRokwRk4BXSRZwOhSKl3GgOIaYyTIlhx66QuHHp7h4EQ_rxXoExa4WZktmxFvSxdz2prWNB1fS9T5sPB_Inx1HoHbsAx_6vUG5kq93cUyxj1iMYUwTuLAoLw5hn4agkE1b88Np5Eewt_KtxzBS-gRq9wBMU20_yTSZaVnryVbJdTCL_dBua80otWe1q9poTN8OX5Royxz0m-zxd2_D0F9ZjESdcvgtewosXz7fF3yn1-atc3iXTfCt__wMJpT3q3NgqBKMZCWxSpWogjlGKMOolJTgKIwETmH65zAX_8gu4cAj0hyvazaDie16dUWe1ZbXftm-AF_Uicg |
link.rule.ids | 230,309,783,805,888,64373 |
linkProvider | USPTO |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB7WVXycFJVdnzl4jbbdbh9ntdTX0oPC3sq0ibLgpqVNEf-9k1QWQfSahGTymJkM-eYLwIXwiwgxdHgZxg6nQyF5ETiSo4uxKCJy6K5JFH6aBemLfz-fzgeQrnJhlqRGvCZZ2suurXVlwZVk3vuN5z35s-EIVIZ94EO9Vygy8XoVBHT38adrsG6eomwglKQ7sEWd0KVN6faH20h2YSOzpXswkGofFuYJmAZbfpJysrZmtaVbJefBNHZ9uV4oRsE9W5i8jart6v6TEqWZAX-TRv5u3TK0RotRVSMNgksfAEtun69TvpIrf2sM4iV3vmcwOYQhRf5yBAxliJ4oBZaR9Etngh4K1ysEhTgSPR_HMP6zm6N_6s5hM7tJ8se72cMxbFt4miF5jU9gqJtOnpKb1cWZXcEvPt2Mwg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Streptomyces+sp+producing+tautomycetin+and+immunosuppressant+comprising+tautomycetin+as+active+ingredient&rft.inventor=Chun%2C+Hyoung+Sik&rft.inventor=Kim%2C+Jong+Gwan&rft.inventor=Chang%2C+Hung+Bae&rft.inventor=Moon%2C+Seung+Kee&rft.inventor=Son%2C+Hyeog+Jin&rft.inventor=Hong%2C+Chung+Il&rft.inventor=Kim%2C+Jung+Woo&rft.inventor=Lyu%2C+Nam+Hyun&rft.number=6608045&rft.date=2003-08-19&rft.externalDBID=n%2Fa&rft.externalDocID=06608045 |